What are the management options for diarrhea in patients taking Wellbutrin (bupropion)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Diarrhea in Patients Taking Wellbutrin (Bupropion)

Loperamide is the first-line treatment for managing diarrhea in patients taking Wellbutrin (bupropion), starting with an initial dose of 4 mg followed by 2 mg every 2-4 hours or after every unformed stool, not exceeding 16 mg daily. 1

Initial Assessment and Non-Pharmacological Management

  • Evaluate the severity of diarrhea by determining the frequency of stools over baseline, stool composition, and presence of nocturnal diarrhea 2
  • Assess for concerning symptoms including fever, orthostatic hypotension, abdominal pain/cramping, or weakness that may indicate complications 2
  • Review medication profile to confirm bupropion as the causative agent and rule out other potential causes 2
  • Implement dietary modifications:
    • Recommend BRAT diet (bananas, rice, applesauce, toast) and plain pasta 1, 2
    • Eliminate lactose-containing products, alcohol, and high-osmolar dietary supplements 2
    • Ensure adequate hydration with 8-10 large glasses of clear liquids daily (e.g., electrolyte solutions, broth) 1, 2
    • Eat frequent small meals rather than large meals 2

Pharmacological Management

First-Line Treatment

  • Loperamide:
    • Initial dose of 4 mg followed by 2 mg every 2-4 hours or after every unformed stool 1
    • Maximum daily dose of 16 mg 1
    • Continue until diarrhea-free for at least 12 hours 2
    • If diarrhea persists for more than 24 hours, increase dosing frequency to 2 mg every 2 hours 2

Second-Line Treatments (For Persistent Diarrhea)

  • Other opioids can be considered if loperamide is ineffective:
    • Tincture of opium 1
    • Low doses of morphine concentrate 1
  • Octreotide:
    • Starting dose of 100-150 μg subcutaneously three times daily 1
    • Can be titrated up to 500 mg subcutaneously three times daily or 25-50 mg/hour by continuous IV infusion 1, 2

For Severe or Persistent Cases

  • Intravenous fluid replacement if dehydration is present 2
  • Consider hospitalization for severe cases with dehydration, electrolyte abnormalities, or significant impact on quality of life 2

Special Considerations

  • While bupropion is more commonly associated with constipation 3, diarrhea can occur as a side effect in some patients 4
  • If diarrhea is severe and persistent despite management, consider discussing with the prescriber about:
    • Dose reduction of bupropion 5
    • Switching to an alternative antidepressant with a different side effect profile, such as mirtazapine, which has fewer gastrointestinal side effects 4
  • Monitor for dehydration and electrolyte imbalances, especially in elderly patients or those with comorbidities 2

Monitoring and Follow-up

  • Instruct patient to record the number of stools and report symptoms of life-threatening sequelae (e.g., fever, dizziness upon standing) 2
  • If symptoms resolve, gradually reintroduce solid foods while continuing dietary modifications 2
  • For patients with persistent symptoms, consider referral to a gastroenterologist to rule out other causes of diarrhea 1

Potential Pitfalls and Caveats

  • Avoid abrupt discontinuation of bupropion without medical supervision, as this may lead to withdrawal symptoms or recurrence of depression 5
  • Be aware that gastrointestinal side effects are common with many antidepressants and may resolve with continued treatment 4
  • If considering bile acid sequestrants (e.g., cholestyramine) for persistent diarrhea, be aware they may interact with bupropion absorption 1
  • Recognize that persistent gastrointestinal symptoms might indicate another underlying condition rather than a medication side effect 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Levetiracetam-Induced Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Severe constipation associated with extended-release bupropion therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.